Variables | eGFR < 60 (N = 94) | eGFR ≥ 60 (N = 1708) | p-value | ||
---|---|---|---|---|---|
N | (%) | N | (%) | ||
Age > 60 | 74 | (78.7) | 560 | (32.8) | < 0.001 |
Female gender | 59 | (62.8) | 431 | (25.2) | < 0.001 |
Comorbidities | |||||
Hypertension | 51 | (54.2) | 640 | (37.4) | < 0.001 |
Diabetes | 42 | (44.7) | 238 | (13.9) | < 0.001 |
Dyslipidemia | 8 | (8.5) | 142 | (8.3) | 0.946 |
Gout | 19 | (20.2) | 348 | (20.5) | 0.952 |
Hyperuricemia | 19 | (20.2) | 248 | (14.5) | 0.130 |
Obesity (BMI > 27) | 29 | (30.9) | 417 | (24.4) | 0.159 |
Stone composition | |||||
Uric acid | 21 | (22.3) | 138 | (8.1) | < 0.001 |
Surgery of stone acquisition | |||||
PCNL | 27 | (28.7) | 322 | (18.9) | 0.019 |
URSL | 52 | (55.3) | 794 | (46.4) | 0.095 |
Cystolithotripsy | 6 | (6.4) | 368 | (21.5) | < 0.001 |
Self-voiding after ESWL | 1 | (1.0) | 180 | (10.5) | 0.003 |